NEW YORK, Jan. 16 (Xinhua) -- U.S. health officials have cleared America's most popular nicotine pouch to stay on the market, saying Zyn's benefit as a safer alternative for adult cigarette smokers outweighed its potential risk to young people.
The Food and Drug Administration (FDA) said Philip Morris International's Zyn pouches pose lower risk of cancer and other serious health conditions than cigarettes or traditional dipping tobacco. The agency said it reviewed data on the risk to young people and found that youth use of nicotine pouches remains low despite growing sales of the pouches in recent years.
